Experimental model for myelodysplastic syndromes uncovers genetic alterations to improve characterization

Myelodysplastic syndromes (MDS) are a group of disorders that typically arise in adulthood, especially after the age of 70, and their five-year survival rate is around 30%. MDS are characterized by defective maturation of blood cells in the bone marrow, leading to a range of health problems such as fatigue and recurrent infections. Without appropriate treatment, they may progress to acute myeloid leukemia, a much more severe disease.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup